{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-006632","form_type":"8-K/A","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2026-08-20T20:15:14+00:00","discovered_at":"2026-08-20T20:16:00.385396+00:00","generated_at":"2026-08-20T20:16:18.590004+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Valion Bio stockholders authorize 1-for-5 to 1-for-50 reverse stock split","bullets":["Special meeting Aug 14, 2026: reverse split proposal approved with 1,243,530 for, 697,127 against, 60,678 abstain.","Board has 12 months to set split ratio within 1-for-5 to 1-for-50 range without further stockholder approval.","Quorum was 48.21% (2,001,335 of 4,151,259 outstanding common shares represented).","Adjornment proposal also passed (1,242,980 for) but not used since Proposal 1 passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-006632","json":"https://secwatch.observer/filing/0001683168-26-006632.json","markdown":"https://secwatch.observer/filing/0001683168-26-006632.md","text":"https://secwatch.observer/filing/0001683168-26-006632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826006632/0001683168-26-006632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826006632/valion_8ka1.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-20T20:16:18.590004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}